Posted 15th April 2020 by Joshua Sewell
Antibiotics consumption is increasing worldwide, yet these therapies not only destroy pathogens but also damage our vital intestinal flora.
Posted 1st April 2020 by Joshua Sewell
Probiotics have been recommended for many conditions during the past century, ranging from long-term immunomodulatory effects to proven benefits in the management of chronic diseases. There is an increased availability of commercial products containing probiotic strains. Do all of them indeed provide health benefits for their consumers? I am convinced they don’t.
Posted 2nd December 2019 by Joshua Sewell
I am extremely sceptical of all claims about probiotics. For the last 10 years of running Probiotics.org, companies have been sending me questionable products with extraordinarily impossible to believe claims.
But, after Global Engage’s 4th Probiotic & Prebiotics Congress, here’s what I strongly believe:
Posted 12th July 2019 by Jane Williams
Numerous skincare brands incorporate lysates in their formulas. However, few brands are able to harness live and active bacteria in addition to the lysates. Neither is an easy task when it comes to formulation however, we can all acknowledge and appreciate the difficulty in working with live probiotics. So, what are the benefits and is this extra challenge worth the effort?
Posted 25th January 2019 by Joshua Sewell
In December 2014, a major flood in north-eastern Peninsular Malaysia affected more than 200,000 people leaving them homeless, with no clean water, and sick with diseases including dengue fever, typhoid, leptospirosis and acute gastroenteritis (approximately 30% of flood-affected population). After 6 months, many were still affected by illness including persistent abdominal pain and diarrhoea. We investigated two of the worst flood-affected communities (Figure A) on their microbiota profile and if a probiotic can help. Following are 5 points I have learned from this invaluable experience:
Posted 18th January 2019 by Jane Williams
Recent progress in science pinpoints that the gut-brain axis may be modulated by a class of probiotics called psychobiotics. These progresses shed lights on a new area of research and new ways to treat a broad spectrum of complex central nervous system diseases.
Posted 24th December 2018 by Jane Williams
2018 has been another big year for the microbiome and probiotics. Investment is at an all-time high with the global probiotics market expected to grow with a compound annual growth rate of 6.5% over the forecast period of 2018-2024, while the microbiome market is predicted to grow from $235.8 million in 2018 to $521.23 million by 2022.